|
| 37454762 | Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19. | Infect Dis Now | 2023 |
| 35527425 | Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people â¿¥65â¿¿years of age. | HIV Medicine | 2023 |
| 36758059 | Prevalence of and risk factors for Human Immunodeficiency Virus (HIV) infection in entrants and residents of an Ethiopian prison. | PLoS One | 2023 |
| 34596223 | Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort. | Clin Infect Dis | 2022 |
| 34125632 | Pilot comparison of the ease of swallowing of single tablet antiretroviral regimens. | AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV | 2022 |
| 34463118 | Comparative effectiveness research in COVID-19 using real-world data: methodological considerations. | Journal of Comparative Effectiveness Research | 2021 |
| 34282406 | Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality. | Open Forum Infectious Diseases | 2021 |
| 33686573 | Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged⿿⿥⿿65 Years: Week 48 Results of a Phase 3b, Open-Label Trial. | Infectious Diseases and Therapy | 2021 |
| 33864370 | Results from a Pre-exposure Prophylaxis Demonstration Project for At-risk Cisgender Women in the United States. | Clin Infect Dis | 2021 |
| 33315694 | Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation. | Journal of acquired immune deficiency syndromes (1999) | 2021 |
| 33252495 | Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV. | AIDS | 2021 |
| 32894754 | Reply to Pandita et al. | Clinical Infectious Diseases | 2021 |
| 34984212 | Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States. | Open Forum Infect Dis | 2021 |
| 31504296 | Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment. | Clinical Infectious Diseases | 2020 |
| 32413134 | Differential detection of M184V/I between plasma historical HIV genotypes and HIV proviral DNA from PBMCs. | Journal of Antimicrobial Chemotherapy | 2020 |
| 31995556 | HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens. | PLoS ONE | 2020 |
| 31988104 | Antiviral Activity of Tenofovir Alafenamide against HIV-1 with Thymidine Analog-Associated Mutations and M184V. | Antimicrobial Agents and Chemotherapy | 2020 |
| 32851110 | PrEP Nonadherence, White Coat Dosing, and HIV Risk Among a Cohort of MSM. | Open Forum Infect Dis | 2020 |
| 31305329 | Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen. | AIDS | 2019 |
| 31578954 | Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a m | Lancet HIV,The | 2019 |
| 31830092 | Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: Prevalence from screening of entrant and resident prisoners. | PLoS One | 2019 |
| 30334877 | Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study Among Individuals at Risk of HIV. | J Acquir Immune Defic Syndr | 2019 |
| 30422909 | Perceived Versus Calculated HIV Risk: Implications for Pre-exposure Prophylaxis Uptake in a Randomized Trial of Men Who Have Sex With Men. | J Acquir Immune Defic Syndr | 2019 |
| 31067122 | Recent HIV Risk Behavior and Partnership Type Predict HIV Pre-Exposure Prophylaxis Adherence in Men Who Have Sex with Men. | AIDS Patient Care STDS | 2019 |
| 29725790 | Randomized Trial of a Health Coaching Intervention to Enhance Retention in Care: California Collaborative Treatment Group 594. | AIDS Behav | 2018 |
| 28597911 | Digitizing Medicines for Remote Capture of Oral Medication Adherence Using Co-encapsulation. | Clinical Pharmacology and Therapeutics | 2018 |
| 29903710 | Analysis of drug-drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription database. | American Journal of Health-System Pharmacy | 2018 |
| 29228144 | Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study. | Clin Infect Dis | 2018 |
| 29091342 | Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials. | Liver Int | 2018 |
| 29370196 | Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults. | PLoS One | 2018 |
| 28134057 | HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen. | HIV Clin Trials | 2017 |
| 28383402 | Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice. | Medicine (Baltimore) | 2017 |
| 28931220 | Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants. | J Infect Dis | 2017 |
| 26487300 | Randomized Controlled Trial of an Internet Application to Reduce HIV Transmission Behavior Among HIV Infected Men Who have Sex with Men. | AIDS Behav | 2016 |
| 26977746 | Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue. | J Acquir Immune Defic Syndr | 2016 |
| 27183217 | Impact of pre-adapted HIV transmission. | Nat Med | 2016 |
| 26721599 | Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy. | Int J Epidemiol | 2016 |
| 26421804 | High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral Therapy. | Pediatric Infectious Disease Journal | 2016 |
| 26678998 | Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. | PLoS One | 2015 |
| 25461247 | Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols. | Pharmacogenet Genomics | 2015 |
| 25884002 | Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols. | Open Forum Infect Dis | 2015 |
| 25542470 | Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure. | J Clin Virol | 2015 |
| 25321179 | Changes in metabolic syndrome status after initiation of antiretroviral therapy. | J Acquir Immune Defic Syndr | 2015 |
| 25616837 | Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP. | AIDS Behav | 2015 |
| 25512628 | Antiretroviral therapy in the elite controller: justified or premature? | Journal of Infectious Diseases | 2015 |
| 26595748 | HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial. | Ann Intern Med | 2015 |
| 26212575 | Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity. | HIV Clin Trials | 2015 |
| 26299251 | Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy. | Sci Rep | 2015 |
| 26061824 | Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men. | PLoS One | 2015 |
| 24789781 | Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment. | J Virol | 2014 |